
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) is currently trading at 138.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Source Natural Foods & Herbal Supplements Limited is a business engaged in the production and sale of allopathic and ayurvedic formulations. The company focuses deeply on R&D to diversify its product portfolio, especially in creating herbal and organic nutritional supplements. Its key products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets, aiming to integrate Ayurveda into daily diets. Despite operational challenges, such as factory shutdowns due to insufficient working capital, the company revived under new management focusing on high-quality Ayurveda products.
Over the past 52 weeks, Source Natural Foods & Herbal Supplements Ltd has traded between a low of ₹118.95 and a high of ₹216.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Source Natural Foods & Herbal Supplements Ltd has a market capitalization of approximately 90.15. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Source Natural Foods & Herbal Supplements Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 30.31 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
You can buy shares of Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.
Based on its market capitalization of 90.15 Cr, Source Natural Foods & Herbal Supplements Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Source Natural Foods & Herbal Supplements Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Source Natural Foods & Herbal Supplements Ltd is 30.31. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Source Natural Foods & Herbal Supplements Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.
Key risks associated with Source Natural Foods & Herbal Supplements Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.
Bearish
1
Neutral
8
Bullish
5
Bearish
7
Neutral
8
Bullish
31
Bearish
6
Neutral
0
Bullish
26

Market Cap
₹ 90 Cr
P/E
30.31
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
90 Cr
Low Risk
30.3
29.9
5.0
3.8
216.00
118.95
Sales CAGR
1Y
64.54%
3Y
27.79%
5Y
24.35%
10Y
15.95%
Profit CAGR
1Y
66.67%
3Y
6.08%
5Y
12.11%
10Y
23.75%
ROE
TTM
12.56%
3Y
11.36%
5Y
14.24%
10Y
14.05%
ROCE
TTM
15.10%
3Y
17.32%
5Y
20.45%
10Y
18.88%
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bullish
Risk
MODERATE RISK